Literature DB >> 9677101

EGF, TGF-alpha, and EGF-R in human colorectal adenocarcinoma.

C Messa1, F Russo, M G Caruso, A Di Leo.   

Abstract

The over-expression of epidermal growth factor receptor (EGF-R), EGF and transforming growth factor alpha (TGFalpha) could be a mechanism for colorectal tumor cells to escape normal growth controls. Our aims were: (i) to evaluate EGF, TGFalpha, and EGF-R concentrations in neoplastic tissue and surrounding mucosa from 40 patients with colorectal adenocarcinoma, and (ii) to assess the expression of these growth factors and their receptor in relation to the tumor site. EGF, TGFalpha, and EGF-R were detected in either colorectal neoplastic tissue or surrounding mucosa. Significantly increased levels of EGF and EGF-R were present in neoplastic samples compared to surrounding mucosa. Furthermore, a significant increase in TGFalpha and in EGF levels was observed in the left-sided surrounding mucosa and left-sided neoplastic tissue, respectively. EGF-R stimulation by its ligands may play an important role in colorectal neoplastic tissue. Moreover, the higher content of growth factors in the left-side than the right-side colon suggests different growth properties in the proximal and distal colon.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9677101     DOI: 10.1080/028418698429595

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  55 in total

1.  HGF rescues colorectal cancer cells from EGFR inhibition via MET activation.

Authors:  David Liska; Chin-Tung Chen; Thomas Bachleitner-Hofmann; James G Christensen; Martin R Weiser
Journal:  Clin Cancer Res       Date:  2010-11-22       Impact factor: 12.531

2.  Frequent Ki-ras mutations and transforming growth factor-alpha expression in adenocarcinomas of the small intestine: report of 7 cases.

Authors:  Hiroyuki Mitomi; Takatoshi Nakamura; Atsushi Ihara; Yoshimasa Otani; Miwa Sada; Masahiro Igarashi; Fumiyuki Akino; Masaaki Ichinoe; Tatsuya Ojima; Akio Mori; Isao Okayasu
Journal:  Dig Dis Sci       Date:  2003-01       Impact factor: 3.199

Review 3.  Targeting non-malignant disorders with tyrosine kinase inhibitors.

Authors:  Friedrich Grimminger; Ralph T Schermuly; Hossein A Ghofrani
Journal:  Nat Rev Drug Discov       Date:  2010-12       Impact factor: 84.694

4.  Assessment of Epidermal Growth Factor Receptor (EGFR) expression in human meningioma.

Authors:  A Gabriella Wernicke; Adam P Dicker; Michal Whiton; Jana Ivanidze; Terry Hyslop; Elizabeth H Hammond; Arie Perry; David W Andrews; Lawrence Kenyon
Journal:  Radiat Oncol       Date:  2010-05-30       Impact factor: 3.481

5.  A role for the epidermal growth factor receptor signaling in development of intestinal serrated polyps in mice and humans.

Authors:  Gerold Bongers; Luciana R Muniz; Michelle E Pacer; Alina C Iuga; Nanthakumar Thirunarayanan; Erik Slinger; Martine J Smit; E Premkumar Reddy; Lloyd Mayer; Glaucia C Furtado; Noam Harpaz; Sergio A Lira
Journal:  Gastroenterology       Date:  2012-05-26       Impact factor: 22.682

Review 6.  Cell surface molecules and their prognostic values in assessing colorectal carcinomas.

Authors:  J Haier; M Nasralla; G L Nicolson
Journal:  Ann Surg       Date:  2000-01       Impact factor: 12.969

7.  Integrating anti-EGFR therapies in metastatic colorectal cancer.

Authors:  Sigurdis Haraldsdottir; Tanios Bekaii-Saab
Journal:  J Gastrointest Oncol       Date:  2013-09

Review 8.  Review of systemic therapies for locally advanced and metastatic rectal cancer.

Authors:  Patrick Yaffee; Arsen Osipov; Carlyn Tan; Richard Tuli; Andrew Hendifar
Journal:  J Gastrointest Oncol       Date:  2015-04

Review 9.  Exploiting novel molecular targets in gastrointestinal cancers.

Authors:  Wen W Ma; Manuel Hidalgo
Journal:  World J Gastroenterol       Date:  2007-11-28       Impact factor: 5.742

10.  Elimination of Colon Cancer Stem-Like Cells by the Combination of Curcumin and FOLFOX.

Authors:  Yingjie Yu; Shailender S Kanwar; Bhaumik B Patel; Jyoti Nautiyal; Fazlul H Sarkar; Adhip Pn Majumdar
Journal:  Transl Oncol       Date:  2009-12       Impact factor: 4.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.